US Stock MarketDetailed Quotes

EDSA Edesa Biotech

Watchlist
  • 4.4000
  • +0.2480+5.97%
Close May 30 16:00 ET
  • 4.4900
  • +0.0900+2.05%
Post 16:01 ET
14.15MMarket Cap-1872P/E (TTM)

Edesa Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-5.60%-1.66M
21.47%-1.41M
45.95%-6.64M
73.92%-1.47M
40.36%-1.81M
-277.33%-1.57M
44.16%-1.79M
10.14%-12.28M
-1,483.98%-5.63M
2.97%-3.03M
Net income from continuing operations
20.26%-1.86M
28.11%-1.68M
52.28%-8.37M
38.86%-1.72M
65.70%-1.98M
48.91%-2.33M
46.68%-2.33M
-31.52%-17.55M
23.66%-2.81M
-21.59%-5.79M
Depreciation and amortization
66.26%45.4K
65.57%45.03K
55.24%183.47K
58.74%45.97K
180.45%83K
-8.62%27.31K
-8.59%27.2K
-0.51%118.19K
0.09%28.96K
-5.16%29.6K
Change In working capital
-95.34%20.85K
-76.74%42.54K
-89.35%308K
90.58%-310.73K
-100.53%-11.47K
-87.19%447.35K
-65.63%182.85K
179.50%2.89M
-237.63%-3.3M
325.97%2.17M
-Change in receivables
-596.45%-384.53K
-109.39%-99.59K
-72.24%562.77K
-562.87%-586.36K
106.74%11.3K
-95.26%77.46K
145.01%1.06M
162.77%2.03M
-83.73%126.68K
-104.72%-167.7K
-Change in prepaid assets
139.75%199.3K
-33.02%38.66K
1,646.41%301.5K
-500.89%-37.53K
257.20%198.18K
-70.71%83.13K
130.94%57.72K
93.07%-19.5K
-99.15%9.36K
-123.37%-126.07K
-Change in payables and accrued expense
-28.14%206.07K
111.06%103.46K
-163.01%-556.27K
109.12%313.16K
-108.99%-220.95K
-81.77%286.77K
-427.21%-935.25K
807.84%882.84K
-772.49%-3.44M
168.55%2.46M
Cash from discontinued investing activities
Operating cash flow
-5.60%-1.66M
21.47%-1.41M
45.95%-6.64M
73.92%-1.47M
40.36%-1.81M
-277.33%-1.57M
44.16%-1.79M
10.14%-12.28M
-1,483.98%-5.63M
2.97%-3.03M
Investing cash flow
Cash flow from continuing investing activities
0
0
7.97%-5.66K
-97.20%41
61.33%-1.36K
Net PPE purchase and sale
----
----
--0
--0
----
----
----
7.97%-5.66K
-97.20%41
61.33%-1.36K
Cash from discontinued investing activities
Investing cash flow
----
--0
--0
--0
----
----
--0
7.97%-5.66K
-97.20%41
61.33%-1.36K
Financing cash flow
Cash flow from continuing financing activities
-72.31%211.73K
-89.50%305.74K
-58.47%4.83M
144,318.53%412.47K
741.23K
-92.65%764.64K
137.02%2.91M
-17.96%11.63M
-100.13%-286
0
Net common stock issuance
--275.8K
-89.59%315.2K
-63.66%4.35M
403,043.33%483.77K
--833.75K
--0
135.21%3.03M
-5.57%11.96M
100.09%120
--0
Proceeds from stock option exercised by employees
----
----
--770.53K
--1
--0
----
----
--0
--0
--0
Net other financing activities
-486.73%-34.56K
91.83%-9.46K
12.99%-285.44K
-17,463.55%-71.31K
---92.52K
97.81%-5.89K
-97.26%-115.72K
-74.16%-328.06K
-100.25%-406
--0
Cash from discontinued financing activities
Financing cash flow
-72.31%211.7K
-89.50%305.74K
-58.47%4.83M
144,318.53%412.47K
--741.23K
-92.65%764.64K
137.02%2.91M
-17.96%11.63M
-100.13%-286
--0
Net cash flow
Beginning cash position
-48.40%4.27M
-24.39%5.36M
-9.55%7.09M
-49.59%6.46M
-52.97%7.47M
40.63%8.27M
-9.55%7.09M
8.67%7.84M
59.06%12.81M
44.87%15.89M
Current changes in cash
-79.37%-1.45M
-198.22%-1.1M
-175.64%-1.81M
81.25%-1.06M
64.86%-1.06M
-108.09%-807.51K
156.54%1.12M
-230.11%-655.33K
-4,137.65%-5.63M
2.54%-3.03M
Effect of exchange rate changes
-330.36%-19.7K
-87.76%7.18K
182.63%76.85K
54.99%-40.22K
199.22%49.91K
-62.65%8.55K
146.87%58.61K
-176.30%-93.01K
-10.99%-89.34K
-125.99%-50.3K
End cash Position
-62.53%2.8M
-48.40%4.27M
-24.39%5.36M
-24.39%5.36M
-49.59%6.46M
-52.97%7.47M
40.63%8.27M
-9.55%7.09M
-9.55%7.09M
59.06%12.81M
Free cash flow
-5.60%-1.66M
21.47%-1.41M
45.98%-6.64M
73.92%-1.47M
40.39%-1.81M
-276.24%-1.57M
44.22%-1.79M
10.14%-12.28M
-1,490.52%-5.63M
3.04%-3.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -5.60%-1.66M21.47%-1.41M45.95%-6.64M73.92%-1.47M40.36%-1.81M-277.33%-1.57M44.16%-1.79M10.14%-12.28M-1,483.98%-5.63M2.97%-3.03M
Net income from continuing operations 20.26%-1.86M28.11%-1.68M52.28%-8.37M38.86%-1.72M65.70%-1.98M48.91%-2.33M46.68%-2.33M-31.52%-17.55M23.66%-2.81M-21.59%-5.79M
Depreciation and amortization 66.26%45.4K65.57%45.03K55.24%183.47K58.74%45.97K180.45%83K-8.62%27.31K-8.59%27.2K-0.51%118.19K0.09%28.96K-5.16%29.6K
Change In working capital -95.34%20.85K-76.74%42.54K-89.35%308K90.58%-310.73K-100.53%-11.47K-87.19%447.35K-65.63%182.85K179.50%2.89M-237.63%-3.3M325.97%2.17M
-Change in receivables -596.45%-384.53K-109.39%-99.59K-72.24%562.77K-562.87%-586.36K106.74%11.3K-95.26%77.46K145.01%1.06M162.77%2.03M-83.73%126.68K-104.72%-167.7K
-Change in prepaid assets 139.75%199.3K-33.02%38.66K1,646.41%301.5K-500.89%-37.53K257.20%198.18K-70.71%83.13K130.94%57.72K93.07%-19.5K-99.15%9.36K-123.37%-126.07K
-Change in payables and accrued expense -28.14%206.07K111.06%103.46K-163.01%-556.27K109.12%313.16K-108.99%-220.95K-81.77%286.77K-427.21%-935.25K807.84%882.84K-772.49%-3.44M168.55%2.46M
Cash from discontinued investing activities
Operating cash flow -5.60%-1.66M21.47%-1.41M45.95%-6.64M73.92%-1.47M40.36%-1.81M-277.33%-1.57M44.16%-1.79M10.14%-12.28M-1,483.98%-5.63M2.97%-3.03M
Investing cash flow
Cash flow from continuing investing activities 007.97%-5.66K-97.20%4161.33%-1.36K
Net PPE purchase and sale ----------0--0------------7.97%-5.66K-97.20%4161.33%-1.36K
Cash from discontinued investing activities
Investing cash flow ------0--0--0----------07.97%-5.66K-97.20%4161.33%-1.36K
Financing cash flow
Cash flow from continuing financing activities -72.31%211.73K-89.50%305.74K-58.47%4.83M144,318.53%412.47K741.23K-92.65%764.64K137.02%2.91M-17.96%11.63M-100.13%-2860
Net common stock issuance --275.8K-89.59%315.2K-63.66%4.35M403,043.33%483.77K--833.75K--0135.21%3.03M-5.57%11.96M100.09%120--0
Proceeds from stock option exercised by employees ----------770.53K--1--0----------0--0--0
Net other financing activities -486.73%-34.56K91.83%-9.46K12.99%-285.44K-17,463.55%-71.31K---92.52K97.81%-5.89K-97.26%-115.72K-74.16%-328.06K-100.25%-406--0
Cash from discontinued financing activities
Financing cash flow -72.31%211.7K-89.50%305.74K-58.47%4.83M144,318.53%412.47K--741.23K-92.65%764.64K137.02%2.91M-17.96%11.63M-100.13%-286--0
Net cash flow
Beginning cash position -48.40%4.27M-24.39%5.36M-9.55%7.09M-49.59%6.46M-52.97%7.47M40.63%8.27M-9.55%7.09M8.67%7.84M59.06%12.81M44.87%15.89M
Current changes in cash -79.37%-1.45M-198.22%-1.1M-175.64%-1.81M81.25%-1.06M64.86%-1.06M-108.09%-807.51K156.54%1.12M-230.11%-655.33K-4,137.65%-5.63M2.54%-3.03M
Effect of exchange rate changes -330.36%-19.7K-87.76%7.18K182.63%76.85K54.99%-40.22K199.22%49.91K-62.65%8.55K146.87%58.61K-176.30%-93.01K-10.99%-89.34K-125.99%-50.3K
End cash Position -62.53%2.8M-48.40%4.27M-24.39%5.36M-24.39%5.36M-49.59%6.46M-52.97%7.47M40.63%8.27M-9.55%7.09M-9.55%7.09M59.06%12.81M
Free cash flow -5.60%-1.66M21.47%-1.41M45.98%-6.64M73.92%-1.47M40.39%-1.81M-276.24%-1.57M44.22%-1.79M10.14%-12.28M-1,490.52%-5.63M3.04%-3.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg